Safingol and Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Status:
Completed
Trial end date:
2009-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as cisplatin, work in different ways to stop
tumor cells from dividing so they stop growing or die. Safingol may stop the growth of tumor
cells by blocking the enzymes necessary for their growth and by stopping blood flow to the
tumor.
PURPOSE: This phase I trial is studying the side effects and best dose of safingol when given
with cisplatin in treating patients with locally advanced or metastatic solid tumors.